These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 31435976)

  • 1. Impact of type 2 diabetes mellitus and physical activity on medication costs in older adults.
    Kikuti-Koyama KA; Monteiro HL; Ribeiro Lemes Í; de Morais LC; Fernandes R; Turi-Lynch B; Codogno J
    Int J Health Plann Manage; 2019 Oct; 34(4):e1774-e1782. PubMed ID: 31435976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Syndrome, Physical Activity, and Medication-Related Expenditures: A Longitudinal Analysis.
    Lemes ÍR; Fernandes RA; Turi-Lynch BC; Codogno JS; de Morais LC; Koyama KAK; Monteiro HL
    J Phys Act Health; 2019 Oct; 16(10):830-835. PubMed ID: 31365903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physical activity and healthcare cost of type 2 diabetic patients seen at basic units of healthcare].
    Codogno JS; Fernandes RA; Monteiro HL
    Arq Bras Endocrinol Metabol; 2012 Feb; 56(1):6-11. PubMed ID: 22460189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of physical activity on type 2 diabetes public healthcare expenditures among adults: a retrospective study.
    Codogno JS; Fernandes RA; Sarti FM; Freitas Júnior IF; Monteiro HL
    BMC Public Health; 2011 May; 11():275. PubMed ID: 21542924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study.
    Balkrishnan R; Rajagopalan R; Camacho FT; Huston SA; Murray FT; Anderson RT
    Clin Ther; 2003 Nov; 25(11):2958-71. PubMed ID: 14693318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population.
    Bergeson JG; Worley K; Louder A; Ward M; Graham J
    J Manag Care Pharm; 2013 Jun; 19(5):374-84. PubMed ID: 23697475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
    Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
    Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Costs involved in the early and late phases of diabetes mellitus].
    Liebl A
    Internist (Berl); 2007 Jul; 48(7):708-14. PubMed ID: 17576527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012.
    Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
    Clin Ther; 2016 Jun; 38(6):1314-1326. PubMed ID: 27129399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
    Reed SD; Li Y; Leal J; Radican L; Adler AI; Alfredsson J; Buse JB; Green JB; Kaufman KD; Riefflin A; Van de Werf F; Peterson ED; Gray AM; Holman RR;
    Diabetes Obes Metab; 2018 Jul; 20(7):1732-1739. PubMed ID: 29573215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological trends and direct costs of diabetes in a Northern Italy area: 2012 health administrative records analysis LHT n. 20 Verona.
    Demurtas J; Alba N; Rigon G; Nesoti MV; Bovo C; Vaona A
    Prim Care Diabetes; 2017 Dec; 11(6):570-576. PubMed ID: 28663023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Physical Activity on Mitigation of Health Care Costs Related to Diabetes Mellitus: Findings from Developed and Developing Settings.
    Turi BC; Monteiro HL; Fernandes RA; Codogno JS
    Curr Diabetes Rev; 2016; 12(4):307-311. PubMed ID: 26472573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes.
    Mody R; Kalsekar I; Kavookjian J; Iyer S; Rajagopalan R; Pawar V
    J Diabetes Complications; 2007; 21(2):75-83. PubMed ID: 17331855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of diabetes-attributable non-blood glucose-lowering medication costs in type 2 diabetes: the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Diabetes Care; 2005 Feb; 28(2):329-36. PubMed ID: 15677788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical costs of managed care in patients with type 2 diabetes mellitus.
    Bhattacharyya SK; Else BA
    Clin Ther; 1999 Dec; 21(12):2131-42. PubMed ID: 10645758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare costs among adults with type 2 diabetes initiating saxagliptin or linagliptin: a US-based claims analysis.
    Kong AM; Farahbakhshian S; Pendergraft T; Brouillette MA; Mukherjee B; Smith DM; Sheehan JJ
    Curr Med Res Opin; 2017 Oct; 33(10):1869-1877. PubMed ID: 28613952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
    Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
    Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to Oral Antihyperglycemic Agents Among Older Adults With Mental Disorders and Its Effect on Health Care Costs, Quebec, Canada, 2005-2008.
    Gentil L; Vasiliadis HM; Préville M; Berbiche D
    Prev Chronic Dis; 2015 Dec; 12():E230. PubMed ID: 26719900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007; 29 Spec No():1294-305. PubMed ID: 18046929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.